Baxter International

Baxter International FCF Yield

The Free Cash Flow Yield of Baxter International (BAX) as of Oct 20, 2026 is 3.17 %. In the previous year, Free Cash Flow Yield was 5.49 % — a change of -42.22% (lower).

FCF Yield

3.17 %

YoY

-42.22%

Last updated:

Free Cash Flow Yield of Baxter International is 2025 3.17 % . Free Cash Flow Yield of Baxter International was 2024 5.49 % . It decreases by -42.22% lower compared to the previous year.

The Baxter International FCF Yield history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

FCF Yield
Date
FCF Yield
Jan 1, 2018
13.34 USD
Jan 1, 2019
13.83 USD
Jan 1, 2020
11.38 USD
Jan 1, 2021
14.53 USD
Jan 1, 2022
5.23 USD
Jan 1, 2023
12.67 USD
Jan 1, 2024
5.49 USD
Jan 1, 2025
3.17 USD
The Baxter International FCF Yield history
YEARFCF YieldYoY
3.17 %-42.22%
5.49 %-56.67%
12.67 %+142.48%
5.23 %-64.03%
14.53 %+27.61%
11.38 %-17.68%
13.83 %+3.68%
13.34 %+23.68%
10.78 %+17.43%
9.18 %+8.72%
8.45 %-62.45%
22.49 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Baxter International Stock analysis

What does Baxter International do? Baxter International Inc is a global company specialized in the development, manufacturing, and marketing of medical therapy products to improve the lives of patients worldwide. It was originally founded in 1931 as the American Hospital Supply Corporation. Since then, the company has continuously evolved and is now a leading provider of medical products and services. The company's history began in 1931 with the founding of the American Hospital Supply Corporation in Illinois. Over the years, the company acquired several small companies and expanded its range of medical products and services. In 1985, the company changed its name to Baxter Travenol Laboratories, Inc. and merged with Travenol Laboratories, Inc. Finally, in 1995, it was renamed Baxter International Inc. to reflect the international focus of the company. Baxter International Inc can be considered as a manufacturer and supplier of medical products in various areas of healthcare. The company is divided into several divisions to better structure and organize its different product and service offerings. The main divisions of the company are infusion systems and devices, parenteral nutrition, renal care products, biopharmaceuticals, and drug delivery systems and bottles. The infusion systems and devices division represents the largest share of Baxter International Inc's revenue. This division is involved in the manufacturing and marketing of products such as infusion pumps and tubing systems, which allow the precise and controlled delivery of fluids and medications into a patient's body. Another important area of Baxter International Inc is the manufacturing of parenteral nutrition. This involves the production of complex nutrient mixtures that are directly injected into the patient's vein when they are unable to receive nutrients in other ways. The company offers a variety of parenteral nutrition solutions enriched with carbohydrates, amino acids, and fats. The renal care products division of Baxter International is specialized in the development and manufacturing of devices and materials necessary for dialysis. Baxter International offers a wide range of dialysis machines and solutions that can be used in the treatment of patients with kidney problems. The company has also developed an extensive range of pediatric devices and solutions to meet the needs of children and adults. The biopharmaceuticals division of Baxter International Inc. focuses on the development and production of innovative medications. The company has a particular focus on the treatment of diseases such as hemophilia and immune disorders. Baxter International Inc. also distributes therapies that can be used to treat various diseases such as cancer or neurological disorders. The drug delivery systems and bottles division is responsible for the manufacturing of accessories, including bottles, bags, and connectors. The company develops and produces a variety of products focusing on drug administration, such as specialized bottles and syringes. Baxter International Inc. offers a wide range of products aimed at improving the health and lives of patients. In addition to infusion pumps and parenteral nutrition, the company also provides wound care devices, blood donation systems, vaccines, and much more. Product development is always tailored to the needs of end-users to ensure the highest possible quality of products and services. In conclusion, Baxter International Inc has established itself as a leading company in the medical and healthcare industry. The expansion of its product range, international focus, and emphasis on meeting the needs of end-users have contributed to the company's continuous growth and success. Furthermore, the company has made a significant contribution to improving healthcare worldwide through its products and services. Baxter International is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Baxter International stock

Free Cash Flow Yield of Baxter International is 3.17 % in 2025.

Free Cash Flow Yield of Baxter International changed from 5.49 % to 3.17 %, representing a -42.22% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Free Cash Flow Yield Baxter International since 2006 – with annual values, charts, and detailed analysis.

FCF Yield measures the free cash flow per share relative to the stock price. It indicates how much cash a company generates for each dollar invested.

To evaluate Free Cash Flow Yield's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Free Cash Flow Yield.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Free Cash Flow Yield's Baxter International with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — Baxter International

All Key Metrics — Baxter International